Lithium Ion

Lithium Ion

SCHEMBL8749265

[Li+].c1csc([Cu-]c2cccs2)c1

nearest known ligand 0.38

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

GSK3AGSK3BIMPA1

The experimentally established mechanism targets of Lithium Ion. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FBP1 P09467 1/20 0.38
CES2 O00748 1/20 0.35
CES1 P23141 1/20 0.35
TSHR P16473 1/20 0.35
HSD17B10 Q99714 1/20 0.35
NPC1 O15118 3/20 0.33
RAB9A P51151 3/20 0.33
DAO P14920 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
MEN1 O00255 3/20 0.32
KMT2A Q03164 3/20 0.32
PRCP P42785 1/20 0.32
SIGMAR1 Q99720 1/20 0.32
HCAR2 Q8TDS4 1/20 0.32
ALDH1A1 P00352 2/20 0.32
ATM Q13315 1/20 0.32
TAAR1 Q96RJ0 1/20 0.32
KDM4E B2RXH2 1/20 0.32
MAPT P10636 1/20 0.32
HPGD P15428 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Lithium Ion SCHEMBL8749310 0.78
Lithium Ion SCHEMBL9534043 0.72
SCHEMBL23039 0.63
Bromide SCHEMBL7869699 0.63 L3MBTL1 (0.52) HSD17B10NPC1RAB9ASMN1; SMN2MEN1
Bromide SCHEMBL1453982 0.61
Bromide SCHEMBL2851138 0.61
SCHEMBL516321 0.61 FBP1 (0.39) FBP1CES2CES1TSHRHSD17B10
Bromide SCHEMBL27529818 0.61
Lithium Ion SCHEMBL8563402 0.61
SCHEMBL3545 0.60 L3MBTL1 (0.57) FBP1HSD17B10NPC1RAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0459381-B1 Process for the preparation of 10-(2-propynyl)ester-4-ene-3,17-dione MERRELL PHARMA INC (US) 1997-03-19 EP disclosed
US-5516922-A Process for the preparation of 10(2-propynyl)estr-4-ene-3,17-dione MERRELL PHARMACEUTICALS INC. (US) 1996-05-14 US disclosed
EP-0459381-A2 Process for the preparation of 10-(2-propynyl)ester-4-ene-3,17-dione MERRELL PHARMACEUTICALS INC. (US) 1991-12-04 EP disclosed